Cryoport’s cryogenic cold chain assists malaria research

Liquid nitrogen cryogenic

Cryoport, Inc., the cryogenic logistics company dedicated to the life sciences industry, has announced that it will assist Sanaria Inc. in the design and implementation of the cryogenic cold chain for Sanaria’s investigational malaria vaccines.

You must be a subsciber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World


Get instant access to must-read content from top industry writers!

To access hundreds of features, subscribe today! Discover the in-depth content our subscribers receive every month by reading this week’s free feature. Join gasworld and become a subscriber to access all of our content from just $250 per annum, or if you are only interested in North American content, pay just $190!